Jeff Yass’s Kairos Pharma KAPA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-4,185
Closed -$11.2K – 14797
2026
Q2
$11.2K Buy
+4,185
New +$15.2K ﹤0.01% 13115

Other funds holding KAPA

Jeff Yass's KAPA Position: Q3 2026 in Review

Jeff Yass sold out of Kairos Pharma (KAPA) in Q3 2026, closing a stake of 4,185 shares — an estimated $11.2K sold.

Jeff Yass first reported a position in KAPA in Q2 2026 and held it in 1 quarter. The position peaked at $11.2K in Q2 2026. 5 funds tracked by Wall St. Rank hold KAPA as of Q3 2026.

  • Jeff Yass reported no remaining Kairos Pharma position as of Q3 2026 after selling out during the quarter.
  • Jeff Yass sold 4,185 Kairos Pharma shares in Q3 2026, an estimated $11.2K.
  • Jeff Yass first reported a position in Kairos Pharma in Q2 2026 and held it in 1 quarter.
  • Jeff Yass's Kairos Pharma position peaked at $11.2K in Q2 2026.
  • 5 funds tracked by Wall St. Rank held Kairos Pharma as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.